PULSE BIOSCIENCES, INC. — Director's Dealing 2023

Mar 24, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pulse Biosciences, Inc. (PLSE)
CIK: 0001625101
Period of Report: 2022-03-22

Reporting Person: Levinson Mitchell E. (Chief Strategy Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-03-22	Stock Option (right to buy)	$2.92	A	35000	Acquired	2033-03-22	Common Stock (35000)	Direct

Footnotes

F1: The option was granted on March 22, 2023 under the Issuer's 2017 Equity Incentive Plan. The shares subject to the option are subject to performance-based vesting criteria. 8,750 shares will vest in equal annual installments over the following four years on or about December 31, starting in 2023, subject to achievement of the vesting criteria and the reporting person's continued service through each vesting date.

F2: Not Applicable